Lorusso D - Search Results

1

Immunotherapy and epithelial ovarian cancer: a double-edged sword?

Ray-Coquard I, Lorusso D. Ray-Coquard I, et al. Among authors: lorusso d. Ann Oncol. 2017 May 1;28(5):909-910. doi: 10.1093/annonc/mdx102. Ann Oncol. 2017. PMID: 28379282 Free article. No abstract available.

2

Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients.

Lorusso D, Ferrandina G, Greggi S, Gadducci A, Pignata S, Tateo S, Biamonte R, Manzione L, Di Vagno G, Ferrau' F, Scambia G; Multicenter Italian Trials in Ovarian Cancer invesitgators. Lorusso D, et al. Ann Oncol. 2003 Jul;14(7):1086-93. doi: 10.1093/annonc/mdg301. Ann Oncol. 2003. PMID: 12853351 Free article. Clinical Trial.

3

Role of gemcitabine in ovarian cancer treatment.

Lorusso D, Di Stefano A, Fanfani F, Scambia G. Lorusso D, et al. Ann Oncol. 2006 May;17 Suppl 5:v188-94. doi: 10.1093/annonc/mdj979. Ann Oncol. 2006. PMID: 16807454 Free article. Review.

4

Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study.

Ferrandina G, Ludovisi M, De Vincenzo R, Salutari V, Lorusso D, Colangelo M, Prantera T, Valerio MR, Scambia G. Ferrandina G, et al. Among authors: lorusso d. Ann Oncol. 2007 Aug;18(8):1348-53. doi: 10.1093/annonc/mdm136. Epub 2007 Apr 29. Ann Oncol. 2007. PMID: 17470449 Free article. Clinical Trial.

5

The different impact of BRCA mutations on the survival of epithelial ovarian cancer patients: a retrospective single-center experience.

Lorusso D, Cirillo F, Mancini M, Spatti GB, Grijuela B, Ditto A, Raspagliesi F. Lorusso D, et al. Oncology. 2013;85(2):122-7. doi: 10.1159/000353786. Epub 2013 Aug 13. Oncology. 2013. PMID: 23941904

6

Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: taking endometrial cancer trials into the translational era.

Creutzberg CL, Kitchener HC, Birrer MJ, Landoni F, Lu KH, Powell M, Aghajanian C, Edmondson R, Goodfellow PJ, Quinn M, Salvesen HB, Thomas G; GCIG Endometrial Cancer Clinical Trials Planning Meeting. Creutzberg CL, et al. Int J Gynecol Cancer. 2013 Oct;23(8):1528-34. doi: 10.1097/IGC.0b013e3182a26edb. Int J Gynecol Cancer. 2013. PMID: 24257568

7

High-risk borderline ovarian tumors: analysis of clinicopathological features and prognostic impact of different follow-up strategies.

Lorusso D, Ratti M, Ditto A, Raspagliesi F. Lorusso D, et al. Oncology. 2014;87(3):183-92. doi: 10.1159/000360990. Epub 2014 Jul 12. Oncology. 2014. PMID: 25033912

8

Is postoperative computed tomography evaluation a prognostic indicator in patients with optimally debulked advanced ovarian cancer?

Lorusso D, Sarno I, Di Donato V, Palazzo A, Torrisi E, Pala L, Marchiano A, Raspagliesi F. Lorusso D, et al. Oncology. 2014;87(5):293-9. doi: 10.1159/000365357. Epub 2014 Aug 15. Oncology. 2014. PMID: 25139548

9

Fertility sparing surgery in early stage epithelial ovarian cancer.

Ditto A, Martinelli F, Lorusso D, Haeusler E, Carcangiu M, Raspagliesi F. Ditto A, et al. Among authors: lorusso d. J Gynecol Oncol. 2014 Oct;25(4):320-7. doi: 10.3802/jgo.2014.25.4.320. Epub 2014 Jun 18. J Gynecol Oncol. 2014. PMID: 25142621 Free PMC article. Review.

10

Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary.

Reed NS, Gomez-Garcia E, Gallardo-Rincon D, Barrette B, Baumann K, Friedlander M, Kichenadasse G, Kim JW, Lorusso D, Mirza MR, Ray-Coquard I. Reed NS, et al. Among authors: lorusso d. Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S35-41. doi: 10.1097/IGC.0000000000000265. Int J Gynecol Cancer. 2014. PMID: 25341578 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

503 results

Search Page